期刊文献+

乳腺浸润性导管癌中p57^(kip2)、cyclin D1和cyclin E的表达及意义 被引量:4

Expression of p57^(kip2),cyclin D1,and cyclin E and their clinical significances in invasive duct carcinomas of the breast
在线阅读 下载PDF
导出
摘要 目的探讨p57kip2、cyclinD1及cyclinE蛋白在乳腺癌发生、发展中作用。方法用免疫组化SP法检测64例乳腺浸润性导管癌(invasiveductalcarcinoma,IDC)、15例乳腺导管原位癌(ductalcarcinomainsitu,DCIS)和15例癌旁正常乳腺组织中p57kip2、cyclinD1和cyclinE蛋白的表达情况。结果p57kip2、cyclinD1和cyclinE蛋白在IDC的阳性率与在乳腺不同组织之间相比,cyclinD1、cyclinE蛋白在DCIS的阳性率与癌旁正常乳腺组织之间相比差异均有显著性(P≤0.05,P<0.01)。在IDC中,三者表达均与腋窝淋巴结转移有关(P≤0.05,P<0.01),cyclinD1蛋白的表达与组织学分级有关(P<0.01),cyclinE蛋白的表达与肿块大小有关(P<0.01);p57kip2与cyclinD1之间、p57kip2与cyclinE之间的表达均呈负相关(P<0.01)、cyclinD1与cyclinE之间的表达呈正相关(P<0.01)。结论p57kip2蛋白低表达、cyclinD1和cyclinE蛋白高表达可能是乳腺组织恶性转变以及乳腺癌发生淋巴结转移的重要生物学标志,cyclinD1和cyclinE蛋白异常表达是乳腺癌发生的早期事件。联合检测p57kip2、cyclinD1及cyclinE蛋白对预测乳腺癌淋巴结转移有重要意义。 Purpose To investigate the effects of p57^(kip2),cyclin D1,and cyclin E on the development and progression of breast carcinomas. Methods Immunohistochemical S-P method was employed to detect expression of p57^(kip2),cyclin D1,and cyclin E proteins in 64 cases of IDC,15 cases of ductal carcinomas in situ (DCIS),and 15 cases of adjacent normal breast tissues. Results The expression of p57^(kip2),cyclin D1,and cyclin E showed significant difference(P≤0.05)between IDC and breast different tissues. Expression of cyclin D1,cyclin E also showed significant difference between DCIS and normal tissues (P<0.01). In IDC,there was correlation between the respective expression of three proteins with axillary lymph node metastasis(P≤0.05,P<0.01),between expression of cyclin D1 with histological grade(P<0.01),and between expression of cyclin E with tumor size(P<0.01). There was negative correlation between expression of p57^(kip2) and cyclin D1,and between expression of p57^(kip2)and cyclin E(P<0.01),but positive correlation between expression of cyclin D1 and cyclin E(P<0.01). Conclusions The decreased expression of p57^(kip2) and over-expression of cyclin D1,and cyclin E might be important biological markers for malignant transformation in breast tissue and lymph node metastasis of breast carcinomas,and the abnormal expression of cyclin D1,and cyclin E is early event of breast carcinomas. The combined detection of p57^(kip2)、cyclin D1,and cyclin E has positive effects on predicting the lymph node metastasis in breast carcinomas.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2005年第3期282-285,共4页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献14

  • 1Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics, tumours of the breast and female genital organs[ M ]. Lyon: IARC Press,2003: 10 - 9.
  • 2Sherr CJ. Cancer cell cycles[J]. Science,1996,274(5293) :1672-7.
  • 3Matsuoka S,Edwards MC,Bai C,et al. p57^kip2 ,a structurally distinct member of the p21 CIP1 CDK inhibitor family, is a candidate tumor suppressor gene[J]. Genes Dev,1995 ,9 :650 -62.
  • 4Zhang P, Liegeois NJ, Wong C, et al. Altered cell differentiation and proliferation in mice lacking p57^kip2 indicates a role in Beckwith - Wiedemenn syndrome [ J ]. Nature, 1997,387:151 - 8.
  • 5Nijjar T, Wiginton D, Garbe JC,et al. p57 kip2 expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells [ J ]. Cancer Res, 1999,59:5112 - 8.
  • 6Ito Y,Takeda T,Sakon M,et al. Expression of p57Kip2 protein in hepatocellular carcinoma[ J ]. Oncology,2001,61 ( 3 ) :221 - 5.
  • 7岳辉,张宁,冯新莉,麻树人,宋福林,杨明,唐谊海.胰腺癌组织中p57^(kip2)、cyclin E和PCNA表达与临床病理因素的关系[J].癌症,2003,22(7):705-709. 被引量:11
  • 8Schraml P,Bucher C,Bissig H,et al. Cyclin E overexpression and amplification in human tumours [ J ]. J Pathol, 2003,200 ( 3 ): 375- 80.
  • 9Sutherland RL,Musgrove EA. Cyclin D1 and mammary carcinoma:new insights from transgenic mouse models [ J ]. Breast Cancer Res,2002,4( 1 ) :14 -7.
  • 10Bortner DM, Rosenberg MP. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E [ J]. Mol Cell Biol, 1997,17:453 - 9.

二级参考文献45

  • 1李锦清,张昌卿,张亚奇,冯凯涛,元云飞,陈敏山,郭荣平,林小军,李国辉.PCNA、p53蛋白在肝癌临床中的意义[J].癌症,1996,15(1):45-47. 被引量:22
  • 2Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274: 1672-1677.
  • 3Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase(CDKs), growth suppressor and cyclin dependent kinase inhibitors(CDKIs) [J]. J Oncogene,1995, 11:211 -219.
  • 4Kamb A. Cell-cycle regulators and cancer[J]. J Trends Genet,1995, 11: 136- 140.
  • 5Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27^kipl in multistage colorectal carcinogenesis[J].Cancer Res, 1998, 58:114 - 122.
  • 6Hunter T, Pines J. Cyelins and cancer Ⅱ: Cyclins and CDK inhibitors come of age[J]. Cell, 1994,79:573 -576.
  • 7Clurman BE, Roberts JM. Cell cycle and cancer[J]. J National Cancer Institute, 1995, 87:1499 - 1504.
  • 8Matsuoka S, Edwards MC, Bai C, et al. p57^juo2 a structurally distinct member is a candidate tumor suppressor gene[J]. Genes Dev, 1995, 9:650 - 662.
  • 9Orlow 1, lavarone A, Crider-Miller SJ, et al. Cyclin-dependent kinase inhibitor p57^kip2 in soft tissue sarcoma and Wilms tumor[J].Cancer Res, 1996, 56:1219 - 1221.
  • 10Lee MH, Reynisdottir I, Massague J. Cloning of p57^kip2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distrlbution[J]. Genes Dev, 1995, 9:639-649.

共引文献44

同被引文献20

  • 1韩硕,李雪莲,李霓,周宝森.激素受体ER与PR及AR在男性乳腺癌与良性病变组织中的表达[J].中华肿瘤防治杂志,2006,13(12):923-925. 被引量:8
  • 2周正平,肖庆邦,冉丰丰,王进京,郑洪.p57^(KIP2)、cyclin D1和cyclin E在宫颈鳞癌中的表达及意义[J].肿瘤防治研究,2007,34(7):511-513. 被引量:4
  • 3Amant F, Moerman P, Neven P, et al. Endometrial ancer [ J]. Lancet ,2005,366:491 - 505.
  • 4Matsuoka S, Edwards MC, Bai C,et al. p57^KIP2 , a struc- turally distinct member of the p21CIPI Cdk inhibitor fam- ily,is a candidate tumor suppressor gene [ J ]. Genes Dev, 1995,9:650 - 62.
  • 5Guo H, Liu Y, Tian T, et al. Downregulation of p57 acceler- ates the growth and invasion of hepatocellular carcinoma [ J]. Carcinogengsis ,2011,32 : 1897 - 904.
  • 6Pateras I S, Apostolopoulou K, Niforou K, et al. p57kip2 : "Kip" ing the cell under control [ J]. Mol Cancer Res, 2009,7 ( 12 ) : 1902 - 19.
  • 7Gielen S C, Hanekamp E E, Hanifi-Moghaddam P, et al. Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells [ J ]. Int J Gynecol Cancer, 2006,16(1) :110.
  • 8Matsuoka S, Edwards M C, Bai C, et al. p57kip2, a structurally distinct member of the p21ClPl Cdk inhibitor family, is a candidate tumor suppressor gene [ J ]. Genes Dev, 1995,9 (6) :650 - 62.
  • 9Jelinic P, Shaw P. Loss of imprinting and cancer[ J ] J Pathol, 2007,211(3) :261 -8.
  • 10Jin R J, Lho Y S, Wang Y Q, et al. Down regulation of p57kip2 induces prostate cancer in the mouse [ J] - Cancer Res, 2008,68 (10) :3601 -8.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部